Pharmaceuticals, Biotechnology and Life Sciences
Anthony Nolan Cell & Gene Therapy Services will provide umbilical cord blood and cord-derived NK cells to facilitate the development of ONK Therapeutics’ next-generation dual-targeted NK cell therapies
Collaboration supports a common mission to…
Anthony Nolan Cell & Gene Therapy Services will provide umbilical cord blood and cord-derived NK cells to facilitate the development of ONK Therapeutics’ next-generation dual-targeted NK cell therapies
Collaboration supports a common mission to…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Lansoprazole DR…
A total of 9 abstracts presented at the 18th Annual European Neuroendocrine Tumor Society (ENETS) Conference showcasing new data across the patient pathway in neuroendocrine tumors
Latest data from the Phase II CLARINET FORTE study are the subject …
A total of 9 abstracts presented at the 18th Annual European Neuroendocrine Tumor Society (ENETS) Conference showcasing new data across the patient pathway in neuroendocrine tumors
Latest data from the Phase II CLARINET FORTE study are the subject …
Winning five core categories reaffirms Vetter as a trusted solution provider, particularly during globally challenging times
Vetter reaffirms its high performance in customer-critical aspects
Results reflect the positive experience of pharma and b…
Adaptive platform clinical research trial design to expedite potential new treatments for veterans
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been awarded Defense Health Agency fun…
Findings of study published in PLOS One found a highly significant correlation between temperature and the rate of increase in COVID-19
An estimated one degree increase in temperature is associated with a 1% decrease in COVID-19 transmissions, an…
SEATTLE–(BUSINESS WIRE)–#AllogeneicBones–According to Coherent Market Insights, the global regenerative medicine (Bone and Joint) market is estimated to be valued at US$ 7,090.1 million in 2020 and is expected to exhibit a CAGR of 10.3% over the for…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming t…